Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic ReviewLOBMAIER, Philipp P; KUNØE, Nikolaj; GOSSOP, Michael et al.CNS neuroscience & therapeutics (Print). 2011, Vol 17, Num 6, pp 629-636, issn 1755-5930, 8 p.Article

Risk Factors for Craving and Relapse in Heroin Users Treated with Oral or Implant NaltrexoneHULSE, Gary K; NGO, Hanh T. T; TAIT, Robert J et al.Biological psychiatry (1969). 2010, Vol 68, Num 3, pp 296-302, issn 0006-3223, 7 p.Article

Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated miceBAILEY, Alexis; HAWKINS, Rachel M; HOURANI, Susanna M. O et al.British journal of pharmacology. 2003, Vol 139, Num 6, pp 1187-1195, issn 0007-1188, 9 p.Article

A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependenceBALLDIN, J; BERGLUND, M; WILLANDER, A et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 7, pp 1142-1149, issn 0145-6008, 8 p.Article

Pain as a reward: Changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systemsBENEDETTI, Fabrizio; THOEN, Wilma; BLANCHARD, Catherine et al.Pain (Amsterdam). 2013, Vol 154, Num 3, pp 361-367, issn 0304-3959, 7 p.Article

Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboonsKAMINSKI, Barbara J; DUKE, Angela N; WEERTS, Elise M et al.Psychopharmacologia. 2012, Vol 223, Num 1, pp 55-66, issn 0033-3158, 12 p.Article

Adverse events in the removal of naltrexone implantsSADLEIR, P. H. M; GARDNER, A. I; HENNESSY, B et al.Anaesthesia and intensive care. 2011, Vol 39, Num 5, pp 895-898, issn 0310-057X, 4 p.Article

Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysisKAMBIA, Nicolas K; DINE, Thierry; ODOU, Pascal et al.European journal of drug metabolism and pharmacokinetics. 2004, Vol 29, Num 4, pp 225-230, issn 0378-7966, 6 p.Article

How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatmentCAMPANELLA, S; PETIT, G; VERBANCK, P et al.Neurophysiologie clinique (Paris). 2011, Vol 41, Num 3, pp 115-123, issn 0987-7053, 9 p.Article

BIOSYNTHESIS, ISOLATION AND IDENTIFICATION OF 6BETA -HYDROXYNALTREXONE, A MAJOR HUMAN METABOLITE OF NALTREXONE = BIOSYNTHESE, ISOLEMENT ET IDENTIFICATION DE LA 6BETA -HYDROXYNALTREXONE, UN METABOLITE PRINCIPAL DE LA NALTREXONE CHEZ L'HOMMECONE EJ; GORODETZKY CW; YEH SY et al.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 4; PP. 618-621; BIBL. 5REF.Article

Genetic moderators of naltrexone's effects on alcohol cue reactivityMCGEARY, John E; MONTI, Peter M; ROHSENOW, Damaris J et al.Alcoholism, clinical and experimental research. 2006, Vol 30, Num 8, pp 1288-1296, issn 0145-6008, 9 p.Article

Preclinical and Clinical studies on naltrexone: What have they taught each other?FROEHLICH, Janice; O'MALLEY, Stephanie; HYYTIÄ, Petri et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 3, pp 533-539, issn 0145-6008, 7 p.Article

A comparison of the effects of 6-β naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in ratsSTROMBERG, Michael F; RUKSTALIS, Margaret R; MACKLER, Scott A et al.Pharmacology, biochemistry and behavior. 2002, Vol 72, Num 1-2, pp 483-490, issn 0091-3057, 8 p.Article

The effect of naltrexone on the perception and distress in tinnitus: An open-label pilot studyVANNESTE, Sven; AZEVEDO, Andréia; DE RIDDER, Dirk et al.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 1, pp 5-11, issn 0946-1965, 7 p.Article

OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependenceCOLLER, Janet K; CAHILL, Sharon; EDMONDS, Carolyn et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 12, pp 902-905, issn 1744-6872, 4 p.Article

Association of OPRM1 A118G variant with the relative reinforcing value of nicotineRAY, R; JEPSON, C; PATTERSON, F et al.Psychopharmacologia. 2006, Vol 188, Num 3, pp 355-363, issn 0033-3158, 9 p.Article

Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot studyCUCINELLI, Francesco; SORANNA, Liberato; PERRI, Concetta et al.Fertility and sterility. 2004, Vol 81, Num 4, pp 1047-1054, issn 0015-0282, 8 p.Article

Naltrexone for the management of post-burn pruritus : A preliminary reportLASALLE, L; RACHELSKA, G; NEDELEC, B et al.Burns. 2008, Vol 34, Num 6, pp 797-802, issn 0305-4179, 6 p.Article

Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatmentDAVIDSON, Dena; WIRTZ, Philip W; GULLIVER, Suzy Bird et al.Psychopharmacologia. 2007, Vol 194, Num 1, pp 1-10, issn 0033-3158, 10 p.Article

Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexoneDUNBAR, Joi L; TURNCLIFF, Ryan Z; QUNMING DONG et al.Alcoholism, clinical and experimental research. 2006, Vol 30, Num 3, pp 480-490, issn 0145-6008, 11 p.Article

Naltrexone attenuates acute cigarette smoking behaviorEPSTEIN, Alyssa M; KING, Andrea C.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 1, pp 29-37, issn 0091-3057, 9 p.Article

Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinkingANTON, Raymond F; DROBES, David J; VORONIN, Konstantin et al.Psychopharmacologia. 2004, Vol 173, Num 1-2, pp 32-40, issn 0033-3158, 9 p.Article

Effect of Extended-Release Naltrexone (XR-NTX) on Quality of Life in Alcohol-Dependent PatientsPETTINATI, Helen M; GASTFRIEND, David R; QUNMING DONG et al.Alcoholism, clinical and experimental research. 2009, Vol 33, Num 2, pp 350-356, issn 0145-6008, 7 p.Article

Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: Dose-effects and time-courseBIGELOW, George E; PRESTON, Kenzie L; SCHMITTNER, John et al.Drug and alcohol dependence. 2012, Vol 123, Num 1-3, pp 57-65, issn 0376-8716, 9 p.Article

New therapeutic options for alcohol dependence : Long-acting intramuscular formulations of naltrexoneGARBUTT, James C.The Journal of clinical psychiatry. 2006, Vol 67, pp 30-34, issn 0160-6689, 5 p., SUP14Article